CORRECTION -- Gritstone Reports First Quarter 2022
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Specific Neoantigen. Real-time updates on events, politics, business and more.